Second-line HIV treatment in ugandan children: Favorable outcomes and no protease inhibitor resistance

Boerma, Ragna S.
Kityo, Cissy
Boender, T. Sonia
Kaudha, Elizabeth
Kayiwa, Joshua
Musiime, Victor
Mukuye, Andrew
Kiconco, Mary
Nankya, Immaculate
Nakatudde, Lilian
Mugyenyi, Peter N.
van Hensbroek, Michael Boele
de Wit, Tobias F.Rinke
Sigaloff, Kim C.E.
Calis, Job C.J.

Publication date

January 2017

Abstract

Background: Data on pediatric second-line antiretroviral treatment (ART) outcomes are scarce, but essential to evaluate second-line and design third-line regimens. Methods: Children ≤ 12 years switching to second-line ART containing a protease inhibitor (PI) in Uganda were followed for 24 months. Viral load (VL) was determined at switch to second-line and every 6 months thereafter; genotypic resistance testing was done if VL ≥ 1000 cps/ml. Results: 60 children were included in the analysis; all had ≥ 1 drug resistance mutations at switch. Twelve children (20.0%) experienced treatment failure; no PI mutations were detected. Sub-optimal adherence and underweight were associated with treatment failureConclusions: No PI mutations occurred in ch...

Extracted data

We use cookies to provide a better user experience.

Data Protection

Second-line HIV treatment in ugandan children: Favorable outcomes and no protease inhibitor resistance

Boerma, Ragna S.
Kityo, Cissy
Boender, T. Sonia
Kaudha, Elizabeth
Kayiwa, Joshua
Musiime, Victor
Mukuye, Andrew
Kiconco, Mary
Nankya, Immaculate
Nakatudde, Lilian
Mugyenyi, Peter N.
van Hensbroek, Michael Boele
de Wit, Tobias F.Rinke
Sigaloff, Kim C.E.
Calis, Job C.J.

Open link

Publication date

January 2017

Abstract

Extracted data

Huibers, M. H. W.
Kityo, C.
Boerma, R. S.
Kaudha, E.
Sigaloff, K. C. E.
Balinda, S. N.
Bertagnolio, S.
Nakanjako, R.
Mugyenyi, P.
Calis, J. C. J.
Boele van Hensbroek, M.
Rinke de Wit, T. F.

October 2019

OBJECTIVES: To evaluate long-term virological failure (VF) and drug resistance among HIV-infected Ug...

Early virological failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children

Theodore D. Ruel
Moses R. Kamya
Mbchb Mmed Mph
Pelin Li
Edwin D. Charlebois
Mph Phd
Teri Liegler
Grant Dorsey
Md Phd
Philip J. Rosenthal
Diane V. Havlir
Joseph K. Wong
Jane Achan
Mbchb Mmed

October 2015

Background—Without virologic testing, HIV-infected African children starting antiretroviral (ARV)-th...

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial

Szubert, A
Prendergast, A
Spyer, M
Musiime, V
Musoke, P
Bwakura-Dangarembizi, M
Nahirya-Ntege, P
Thomason, M
Ndashimye, E
Nankya, I
Senfuma, O
Mudenge, B
Klein, N
Gibb, D
Walker, A

January 2017

Background: Although WHO recommends viral load (VL) monitoring on antiretroviral therapy (ART), avai...

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance

Boerma, Ragna S.
Kityo, Cissy
Boender, T. Sonia
Kaudha, Elizabeth
Kayiwa, Joshua
Musiime, Victor
Mukuye, Andrew
Kiconco, Mary
Nankya, Immaculate
Nakatudde, Lilian
Mugyenyi, Peter N.
Boele van Hensbroek, Michael
Rinke de Wit, Tobias F.
Sigaloff, Kim C. E.
Calis, Job C. J.

January 2017

Data on pediatric second-line antiretroviral treatment (ART) outcomes are scarce, but essential to e...

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy

Suaysod, Rapeepan
Ngo-Giang-Huong, Nicole
Salvadori, Nicolas
Cressey, Timothy
Kanjanavanit, Suparat
Techakunakorn, Pornchai
Krikajornkitti, Sawitree
Srirojana, Sakulrat
Laomanit, Laddawan
Chalermpantmetagul, Suwalai
Lallemant, Marc
Le Coeur, Sophie
McIntosh, Ken
Traisathit, Patrinee
Jourdain, Gonzague

July 2015

BACKGROUND: Human immunodeficiency virus (HIV)-infected children failing second-line antiretroviral ...

Pediatric Response to Second-Line Antiretroviral Therapy in South Africa

Brian C. Zanoni
Henry Sunpath
Margaret E. Feeney

August 2016

Background: With improved access to pediatric antiretroviral therapy (ART) in resource-limited setti...

Treatment failure in HIV-infected children on second-line protease inhibitor-based antiretroviral therapy

Suaysod, R.
Ngo-Giang-Huong, Nicole
Salvadori, Nicolas
Cressey, T. R.
Kanjanavanit, S.
Techakunakorn, P.
Krikajornkitti, S.
Srirojana, S.
Laomanit, L.
Chalermpantmetagul, S.
Lallemant, Marc
Le Coeur, S.
McIntosh, K.
Traisathit, P.
Jourdain, Gonzague

January 2015

Background. Human immunodeficiency virus (HIV)-infected children failing second-line antiretroviral ...

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor–Based Antiretroviral Therapy

Rapeepan Suaysod
Nicole Ngo-giang-huong
Nicolas Salvadori
Tim R. Cressey
Suparat Kanjanavanit
Suwalai Chalermpantmetagul
Marc Lallemant
Sophie Le Cœur
Kenneth Mcintosh
Patrinee Traisathit
Gonzague Jourdain

October 2016

Background. Human immunodeficiency virus (HIV)–infected children failing second-line antiretroviral ...

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children

Kityo, Cissy
Boerma, Ragna S.
Sigaloff, Kim C.E.
Kaudha, Elizabeth
Calis, Job C.J.
Musiime, Victor
Balinda, Sheila
Nakanjako, Rita
Boender, T. Sonia
Mugyenyi, Peter N.
Rinke de Wit, Tobias F.

September 2017

Background: Pretreatment HIV drug resistance (PDR) can impair virological response to ART, jeopardiz...

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: Adolescents at high risk of failure

Boerma, Ragna S.
Bunupuradah, Torsak
Dow, Dorothy
Fokam, Joseph
Kariminia, Azar
Lehman, Dara
Kityo, Cissy
Musiime, Victor
Palumbo, Paul
Schoffelen, Annelot
Sophan, Sam
Zanoni, Brian
Rinke De Wit, Tobias F.
Calis, Job C.J.
Sigaloff, Kim C.E.

January 2017

Introduction: The number of HIV-infected children and adolescents requiring second-line antiretrovir...

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

Harrison L.
Babiker A.
Castro H.
Compagnucci A.
Fiscus S.
Giaquinto C.
Gibb D. M.
Harper L.
Hughes M.
McKinney R.
Melvin A.
Mofenson L.
Saidi Y.
Smith M. E.
Tudor-Williams G.
Walker A. S.
Brouwers P.
Costello D.
Ferguson E.
Hodge J.
Jennings C.
Warshaw M.
Spector S.
Stiehm E.
Toye M.
Yogev R.
Aboulker J. P.
De Rossi A.
Darbyshire J.
Debre M.
Klein N.
Pillay D.
Brody B.
Hill C.
Lepage P.
Modlin J.
Poziak A.
Rein M.
Robb M.
Fleming T.
Vella S.
Kim K. M.
Bologna R.
Mecikovsky D.
Pineda N.
Sen L.
Mangano A.
Marino S.
Galvez C.
Deluchi G.
Zohrer B.
Zenz W.
Daghofer E.
Pfurtscheller K.
Pabst B.
Gomez M. P.
McNeil P.
Jervis M.
Whyms I.
Kwolfe D.
Scott S.
Mussi-Pinhata M. M.
Issac M. L.
Cervi M. C.
Negrini B. V. M.
Matsubara T. C.
de Souza C. B. S. S.
Gabaldi J. C.
Oliveira R. H.
Sapia M. C.
Abreu T.
Evangelista L.
Pala A.
Fernandes I.
Farias I.
Melo M. F.
Carreira H.
Lira L. M.
della Negra M.
Queiroz W.
Lian Y. C.
Pacola D. P.
Pinto J.
Ferreira F.
Kakehasi F.
Martins L.
Diniz A.
Lobato V.
Diniz M.
Cleto S.
Costa S.
Romeiro J.
Dollfus C.
Tabone M. D.
Courcoux M. F.
Vaudre G.
Dehee A.
Schnuriger A.
Le Gueyades N.
De Bortoli C.
Mechinaud F.
Reliquet V.
Arias J.
Rodallec A.
Andre E.
Falconi I.
Le Pelletier A.
Monpoux F.
Cottalorda J.
Mellul S.
Lachassinne E.
Galimand J.
Rouzioux C.
Chaix M. L.
Benabadji Z.
Pourrat M.
Firtion G.
Rivaux D.
Denon M.
Boudjoudi N.
Nganzali F.
Krivine A.
Meritet J. F.
Delommois G.
Norgeux C.
Guerin C.
Floch C.
Marty L.
Hichou H.
Tournier V.
Faye A.
Le Moal I.
Sellier M.
Dehache L.
Damond F.
Leleu J.
Beniken D.
Alexandre-Castor G.
Neubert J.
Niehues T.
Laws H. J.
Huck K.
Gudowius S.
Loeffler H.
Bellert S.
Ortwin A.
Notheis G.
Wintergerst U.
Hoffman F.
Werthmann A.
Seyboldt S.
Schneider L.
Bucholz B.
Feiterna-Sperling C.
Peiser C.
Nickel R.
Schmitz T.
Piening T.
Muller C.
Warncke G.
Wigger M.
Neubauer R.
Butler K.
Chang A. L.
Belger T.
Menon A.
O'connell M.
Barrett L.
Rochford A.
Goode M.
Hayes E.
McDonagy S.
Walsh A.
Doyle A.
Fanning J.
O'connor M.
Byrne M.
O'sullivan N.
Hyland E.
Giacomet V.
Vigano A.
Colombo I.
Trabattoni D.
Berzi A.
Badolato R.
Schumacher F.
Bennato V.
Brusati M.
Sorlini A.
Spinelli E.
Filisetti M.
Bertulli C.
Rampon O.
Zanchetta M.
Mazza A.
Stringari G.
Rossetti G.
Bernardi S.
Martino A.
Castelli Gattinara G.
Palma P.
Pontrelli G.
Tchidjou H.
Furcas A.
Frillici C.
Mazzei A.
Zoccano A.
Concato C.
Duiculescu D.
Oprea C.
Tardei G.
Abaab F.
Mardarescu M.
Draghicenoiu R.
Otelea D.
Alecsandru L.
Matusa R.
Rugina S.
Ilie M.
Netescu S.
Florea C.
Voicu E.
Poalelungi D.
Belmega C.
Vladau L.
Ramos Amador J. T.
Gonzalez Tome M. I.
Rojo Conejo P.
Fernandez M.
Delgado Garcia R.
Ferrari J. M.
Garcia Lopez M.
Mellado Pena M. J.
Martin Fontelos P.
Jimenez Nacher I.
Munoz Fernandez M. A.
Jimenez J. L.
Garcia Torre A.
Penin M.
Pineiro Perez R.
Garcia Mellado I.
Finn A.
Lajeunesse M.
Hutchison E.
Usher J.
Ball L.
Dunn M.
Sharland M.
Doerholt K.
Storey S.
Donaghy S.
Wells C.
Buckberry K.
Rice P.
McMaster P.
Butler P.
Farmer C.
Shenton J.
Haley H.
Orendi J.
Stroobant J.
Navarante L.
Archer P.
Mazhude C.
Scott D.
O'connell R.
Wong J.
Boddy G.
Shackley F.
Lakshman R.
Hobbs J.
Ball G.
Kudesia G.
Bane J.
Painter D.
Sloper K.
Shah V.
Cheng A.
Aali A.
Ball C.
Hawkins S.
Nayagam D.
Waters A.
Doshi S.
Liebeschuetz S.
Sodiende B.
Shingadia D.
Wong S.
Swan J.
Shah Z.
Collinson A.
Hayes C.
King J.
O'connor K.
Lyall H.
Fidler K.
Walters S.
Foster C.
Hamadache D.
Newbould C.
Monrose C.
Campbell S.
Yeung S.
Cohen J.
Martinez-Allier N.
Melvin D.
Dodge J.
Welch S.
Tatum G.
Gordon A.
Kaye S.
Muir D.
Patel D.
Novelli V.
Gibb D.
Moshal K.
Lambert J.
Flynn J.
Farrelly L.
Clapson M.
Spencer L.
Depala M.
Jacobsen M.
Segal S.
Pollard A.
Yeadon S.
Peng Y.
Dong T.
Jeffries K.
Snelling M.
Smyth A.
Smith J.
Ward B.
Jungmann E.
Ryan C.
Swaby K.
Buckton A.
Smidt E.
Abrams E. J.
Champion S.
Fernandez A. D.
Calo D.
Garrovillo L.
Swaminathan K.
Alford T.
Frere M.
Navarra J.
Borkowsky W.
Deygoo S.
Hastings T.
Akleh S.
Ilmet T.
Mohan K.
Bowen G.
Emmanuel P. J.
Lujan-Zimmerman J.
Rodriguez C.
Johnson S.
Marion A.
Graisbery C.
Casey D.
Lewis G.
Guzman-Cottrill J.
Croteau R.
Acevedo-Flores M.
Gonzalez M.
Angeli L.
Fabregas L.
Valentin P.
Weiner L.
Contello K. A.
Holz W.
Butler M.
Nachman S.
Kelly M. A.
Ferraro D. M.
Rana S.
Reed C.
Yeagley E.
Malheiro A.
Roa J.
Neely M.
Kovacs A.
Homans J.
Rodriguez Lozano Y.
Puga A.
Talero G.
Sellers R.
Lawrence R.
Weinberg G. A.
Murante B.
Laverty S.
Deveikis A.
Batra J.
Chen T.
Michalik D.
Deville J.
Elkins K.
Marks S.
Jackson Alvarez J.
Palm J.
Fineanganofo I.
Keuth M.
Deveikis L.
Tomosada W.
Van Dyke R.
Alchediak T.
Silio M.
Borne C.
Bradford S.
Eloby-Childress S.
Nguyen K.
Rathore M. H.
Alvarez A.
Mirza A.
Mahmoudi S.
Burke M.
Febo I. L.
Lugo L.
Santos R.
Church J. A.
Dunaway T.
Rodier C.
Flynn P.
Patel N.
Discenza S.
Donohoe M.
Luzuriaga K.
Picard D.
Kline M.
Paul M. E.
Shearer W. T.
McMullen-Jackson C.
Chadwick E.
Cagwin E.
Kabat K.
Dieudonne A.
Palumbo P.
Johnson J.
Gaur S.
Cerracchio L.
Foca M.
Jurgrau A.
Vasquez Bonilla S.
Silva G.
Gershon A.
Sullivan J.
Bryson Y.
Frenkel L.
Nelson J.
Hadjou G.
Leonardo S.
Riault Y.
Saidi Y.
Buck L.
Darbyshire J. H.
Forcat S.
Horton J.
Johnson D.
Moore S.
Taylor C.
Collins D.
Buskirk S.
Kamara P.
Nesel C.
Johnson M.
Ferreira A.
Tutko J.
Sprenger H.
Britto P.
Powell C.
Dersimonian R.
Handelsman E.
Ananworanich J.
Belfrage E.
Blanche S.
Bohlin A. B.
Burger D.
Castelli-Gattinara G.
Clayden P.
De Groot R.
Grosch-Worner I.
Lallemant M.
Levy J.
Marczynska M.
Mellado Pena M. J.
Nadal D.
Peckham C.
Rosado L.
Rosso R.
Rudin C.
Scherpbier H.
Stevanovic M.
Thorne C.
Tovo P. A.
Valerius N.

January 2011

Background: Children with HIV will be on antiretroviral therapy (ART) longer than adults, and theref...

Babiker, A
Castro nee Green, H
Compagnucci, A
Fiscus, S
Giaquinto, C
Gibb, D
Harper, L
Harrison, L
Hughes, M
McKinney, R
Melvin, A
Mofenson, L
Saidi, Y
Smith, M
Tudor-Williams, G
Walker, A

January 2011

BACKGROUND: Children with HIV will be on antiretroviral therapy (ART) longer than adults, and theref...

Penpact, 1 Study Team: Babiker A
Castro nee Green, H
Compagnucci, A
Fiscus, S
Giaquinto, Carlo
Gibb, Dm
Harper, L
Harrison, L
Hughes, M
Mckinney, R
Melvin, A
Mofenson, L
Saidi, Y
Smith, Me
Tudor Williams, G
Walker, As
Brouwers, P
Costello, D
Ferguson, E
Fiscus, S
Hodge, J
Hughes, M
Jennings, C
Melvin, A
Mckinney, R
Mofenson, L
Warshaw, M
Smith, Me
Spector, S
Stiehm, E
Toye, M
Yogev, R
Aboulker, Jp
Babiker, A
Castro, H
Compagnucci, A
DE ROSSI, Anita

January 2011

BACKGROUND: Children with HIV will be on antiretroviral therapy (ART) longer than adults, and theref...

Short communication: High rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy

Sigaloff, Kim C.E.
Kayiwa, Joshua
Musiime, Victor
Calis, Job C.J.
Kaudha, Elizabeth
Mukuye, Andrew
Matama, Christine
Nankya, Immaculate
Nakatudde, Lillian
Dekker, John T.
Hamers, Raph L.
Mugyenyi, Peter
Rinke De Wit, Tobias F.
Kityo, Cissy

June 2013

HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of particular c...

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting

Puthanakit, T.
Jourdain, Gonzague
Suntarattiwong, P.
Chokephaibulkit, K.
Siangphoe, U.
Suwanlerk, T.
Prasitsuebsai, W.
Sirisanthana, V.
Kosalaraksa, P.
Petdachai, W.
Hansudewechakul, R.
Waranawat, N.
Ananworanich, J.

January 2012

Background: Limited data exist for the efficacy of second-line antiretroviral therapy among children...

Long-term virological outcomes, failure and acquired resistance in a large cohort of Ugandan children

Huibers, M. H. W.
Kityo, C.
Boerma, R. S.
Kaudha, E.
Sigaloff, K. C. E.
Balinda, S. N.
Bertagnolio, S.
Nakanjako, R.
Mugyenyi, P.
Calis, J. C. J.
Boele van Hensbroek, M.
Rinke de Wit, T. F.

October 2019

OBJECTIVES: To evaluate long-term virological failure (VF) and drug resistance among HIV-infected Ug...

Early virological failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children

Theodore D. Ruel
Moses R. Kamya
Mbchb Mmed Mph
Pelin Li
Edwin D. Charlebois
Mph Phd
Teri Liegler
Grant Dorsey
Md Phd
Philip J. Rosenthal
Diane V. Havlir
Joseph K. Wong
Jane Achan
Mbchb Mmed

October 2015

Background—Without virologic testing, HIV-infected African children starting antiretroviral (ARV)-th...

Szubert, A
Prendergast, A
Spyer, M
Musiime, V
Musoke, P
Bwakura-Dangarembizi, M
Nahirya-Ntege, P
Thomason, M
Ndashimye, E
Nankya, I
Senfuma, O
Mudenge, B
Klein, N
Gibb, D
Walker, A

January 2017

Background: Although WHO recommends viral load (VL) monitoring on antiretroviral therapy (ART), avai...

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance

Boerma, Ragna S.
Kityo, Cissy
Boender, T. Sonia
Kaudha, Elizabeth
Kayiwa, Joshua
Musiime, Victor
Mukuye, Andrew
Kiconco, Mary
Nankya, Immaculate
Nakatudde, Lilian
Mugyenyi, Peter N.
Boele van Hensbroek, Michael
Rinke de Wit, Tobias F.
Sigaloff, Kim C. E.
Calis, Job C. J.

January 2017

Data on pediatric second-line antiretroviral treatment (ART) outcomes are scarce, but essential to e...

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy

Suaysod, Rapeepan
Ngo-Giang-Huong, Nicole
Salvadori, Nicolas
Cressey, Timothy
Kanjanavanit, Suparat
Techakunakorn, Pornchai
Krikajornkitti, Sawitree
Srirojana, Sakulrat
Laomanit, Laddawan
Chalermpantmetagul, Suwalai
Lallemant, Marc
Le Coeur, Sophie
McIntosh, Ken
Traisathit, Patrinee
Jourdain, Gonzague

July 2015

BACKGROUND: Human immunodeficiency virus (HIV)-infected children failing second-line antiretroviral ...

Treatment failure in HIV-infected children on second-line protease inhibitor-based antiretroviral therapy

Suaysod, R.
Ngo-Giang-Huong, Nicole
Salvadori, Nicolas
Cressey, T. R.
Kanjanavanit, S.
Techakunakorn, P.
Krikajornkitti, S.
Srirojana, S.
Laomanit, L.
Chalermpantmetagul, S.
Lallemant, Marc
Le Coeur, S.
McIntosh, K.
Traisathit, P.
Jourdain, Gonzague

January 2015

Background. Human immunodeficiency virus (HIV)-infected children failing second-line antiretroviral ...

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor–Based Antiretroviral Therapy

Rapeepan Suaysod
Nicole Ngo-giang-huong
Nicolas Salvadori
Tim R. Cressey
Suparat Kanjanavanit
Suwalai Chalermpantmetagul
Marc Lallemant
Sophie Le Cœur
Kenneth Mcintosh
Patrinee Traisathit
Gonzague Jourdain

October 2016

Background. Human immunodeficiency virus (HIV)–infected children failing second-line antiretroviral ...

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children

Kityo, Cissy
Boerma, Ragna S.
Sigaloff, Kim C.E.
Kaudha, Elizabeth
Calis, Job C.J.
Musiime, Victor
Balinda, Sheila
Nakanjako, Rita
Boender, T. Sonia
Mugyenyi, Peter N.
Rinke de Wit, Tobias F.

September 2017

Background: Pretreatment HIV drug resistance (PDR) can impair virological response to ART, jeopardiz...

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: Adolescents at high risk of failure

Boerma, Ragna S.
Bunupuradah, Torsak
Dow, Dorothy
Fokam, Joseph
Kariminia, Azar
Lehman, Dara
Kityo, Cissy
Musiime, Victor
Palumbo, Paul
Schoffelen, Annelot
Sophan, Sam
Zanoni, Brian
Rinke De Wit, Tobias F.
Calis, Job C.J.
Sigaloff, Kim C.E.

January 2017

Introduction: The number of HIV-infected children and adolescents requiring second-line antiretrovir...

Harrison L.
Babiker A.
Castro H.
Compagnucci A.
Fiscus S.
Giaquinto C.
Gibb D. M.
Harper L.
Hughes M.
McKinney R.
Melvin A.
Mofenson L.
Saidi Y.
Smith M. E.
Tudor-Williams G.
Walker A. S.
Brouwers P.
Costello D.
Ferguson E.
Hodge J.
Jennings C.
Warshaw M.
Spector S.
Stiehm E.
Toye M.
Yogev R.
Aboulker J. P.
De Rossi A.
Darbyshire J.
Debre M.
Klein N.
Pillay D.
Brody B.
Hill C.
Lepage P.
Modlin J.
Poziak A.
Rein M.
Robb M.
Fleming T.
Vella S.
Kim K. M.
Bologna R.
Mecikovsky D.
Pineda N.
Sen L.
Mangano A.
Marino S.
Galvez C.
Deluchi G.
Zohrer B.
Zenz W.
Daghofer E.
Pfurtscheller K.
Pabst B.
Gomez M. P.
McNeil P.
Jervis M.
Whyms I.
Kwolfe D.
Scott S.
Mussi-Pinhata M. M.
Issac M. L.
Cervi M. C.
Negrini B. V. M.
Matsubara T. C.
de Souza C. B. S. S.
Gabaldi J. C.
Oliveira R. H.
Sapia M. C.
Abreu T.
Evangelista L.
Pala A.
Fernandes I.
Farias I.
Melo M. F.
Carreira H.
Lira L. M.
della Negra M.
Queiroz W.
Lian Y. C.
Pacola D. P.
Pinto J.
Ferreira F.
Kakehasi F.
Martins L.
Diniz A.
Lobato V.
Diniz M.
Cleto S.
Costa S.
Romeiro J.
Dollfus C.
Tabone M. D.
Courcoux M. F.
Vaudre G.
Dehee A.
Schnuriger A.
Le Gueyades N.
De Bortoli C.
Mechinaud F.
Reliquet V.
Arias J.
Rodallec A.
Andre E.
Falconi I.
Le Pelletier A.
Monpoux F.
Cottalorda J.
Mellul S.
Lachassinne E.
Galimand J.
Rouzioux C.
Chaix M. L.
Benabadji Z.
Pourrat M.
Firtion G.
Rivaux D.
Denon M.
Boudjoudi N.
Nganzali F.
Krivine A.
Meritet J. F.
Delommois G.
Norgeux C.
Guerin C.
Floch C.
Marty L.
Hichou H.
Tournier V.
Faye A.
Le Moal I.
Sellier M.
Dehache L.
Damond F.
Leleu J.
Beniken D.
Alexandre-Castor G.
Neubert J.
Niehues T.
Laws H. J.
Huck K.
Gudowius S.
Loeffler H.
Bellert S.
Ortwin A.
Notheis G.
Wintergerst U.
Hoffman F.
Werthmann A.
Seyboldt S.
Schneider L.
Bucholz B.
Feiterna-Sperling C.
Peiser C.
Nickel R.
Schmitz T.
Piening T.
Muller C.
Warncke G.
Wigger M.
Neubauer R.
Butler K.
Chang A. L.
Belger T.
Menon A.
O'connell M.
Barrett L.
Rochford A.
Goode M.
Hayes E.
McDonagy S.
Walsh A.
Doyle A.
Fanning J.
O'connor M.
Byrne M.
O'sullivan N.
Hyland E.
Giacomet V.
Vigano A.
Colombo I.
Trabattoni D.
Berzi A.
Badolato R.
Schumacher F.
Bennato V.
Brusati M.
Sorlini A.
Spinelli E.
Filisetti M.
Bertulli C.
Rampon O.
Zanchetta M.
Mazza A.
Stringari G.
Rossetti G.
Bernardi S.
Martino A.
Castelli Gattinara G.
Palma P.
Pontrelli G.
Tchidjou H.
Furcas A.
Frillici C.
Mazzei A.
Zoccano A.
Concato C.
Duiculescu D.
Oprea C.
Tardei G.
Abaab F.
Mardarescu M.
Draghicenoiu R.
Otelea D.
Alecsandru L.
Matusa R.
Rugina S.
Ilie M.
Netescu S.
Florea C.
Voicu E.
Poalelungi D.
Belmega C.
Vladau L.
Ramos Amador J. T.
Gonzalez Tome M. I.
Rojo Conejo P.
Fernandez M.
Delgado Garcia R.
Ferrari J. M.
Garcia Lopez M.
Mellado Pena M. J.
Martin Fontelos P.
Jimenez Nacher I.
Munoz Fernandez M. A.
Jimenez J. L.
Garcia Torre A.
Penin M.
Pineiro Perez R.
Garcia Mellado I.
Finn A.
Lajeunesse M.
Hutchison E.
Usher J.
Ball L.
Dunn M.
Sharland M.
Doerholt K.
Storey S.
Donaghy S.
Wells C.
Buckberry K.
Rice P.
McMaster P.
Butler P.
Farmer C.
Shenton J.
Haley H.
Orendi J.
Stroobant J.
Navarante L.
Archer P.
Mazhude C.
Scott D.
O'connell R.
Wong J.
Boddy G.
Shackley F.
Lakshman R.
Hobbs J.
Ball G.
Kudesia G.
Bane J.
Painter D.
Sloper K.
Shah V.
Cheng A.
Aali A.
Ball C.
Hawkins S.
Nayagam D.
Waters A.
Doshi S.
Liebeschuetz S.
Sodiende B.
Shingadia D.
Wong S.
Swan J.
Shah Z.
Collinson A.
Hayes C.
King J.
O'connor K.
Lyall H.
Fidler K.
Walters S.
Foster C.
Hamadache D.
Newbould C.
Monrose C.
Campbell S.
Yeung S.
Cohen J.
Martinez-Allier N.
Melvin D.
Dodge J.
Welch S.
Tatum G.
Gordon A.
Kaye S.
Muir D.
Patel D.
Novelli V.
Gibb D.
Moshal K.
Lambert J.
Flynn J.
Farrelly L.
Clapson M.
Spencer L.
Depala M.
Jacobsen M.
Segal S.
Pollard A.
Yeadon S.
Peng Y.
Dong T.
Jeffries K.
Snelling M.
Smyth A.
Smith J.
Ward B.
Jungmann E.
Ryan C.
Swaby K.
Buckton A.
Smidt E.
Abrams E. J.
Champion S.
Fernandez A. D.
Calo D.
Garrovillo L.
Swaminathan K.
Alford T.
Frere M.
Navarra J.
Borkowsky W.
Deygoo S.
Hastings T.
Akleh S.
Ilmet T.
Mohan K.
Bowen G.
Emmanuel P. J.
Lujan-Zimmerman J.
Rodriguez C.
Johnson S.
Marion A.
Graisbery C.
Casey D.
Lewis G.
Guzman-Cottrill J.
Croteau R.
Acevedo-Flores M.
Gonzalez M.
Angeli L.
Fabregas L.
Valentin P.
Weiner L.
Contello K. A.
Holz W.
Butler M.
Nachman S.
Kelly M. A.
Ferraro D. M.
Rana S.
Reed C.
Yeagley E.
Malheiro A.
Roa J.
Neely M.
Kovacs A.
Homans J.
Rodriguez Lozano Y.
Puga A.
Talero G.
Sellers R.
Lawrence R.
Weinberg G. A.
Murante B.
Laverty S.
Deveikis A.
Batra J.
Chen T.
Michalik D.
Deville J.
Elkins K.
Marks S.
Jackson Alvarez J.
Palm J.
Fineanganofo I.
Keuth M.
Deveikis L.
Tomosada W.
Van Dyke R.
Alchediak T.
Silio M.
Borne C.
Bradford S.
Eloby-Childress S.
Nguyen K.
Rathore M. H.
Alvarez A.
Mirza A.
Mahmoudi S.
Burke M.
Febo I. L.
Lugo L.
Santos R.
Church J. A.
Dunaway T.
Rodier C.
Flynn P.
Patel N.
Discenza S.
Donohoe M.
Luzuriaga K.
Picard D.
Kline M.
Paul M. E.
Shearer W. T.
McMullen-Jackson C.
Chadwick E.
Cagwin E.
Kabat K.
Dieudonne A.
Palumbo P.
Johnson J.
Gaur S.
Cerracchio L.
Foca M.
Jurgrau A.
Vasquez Bonilla S.
Silva G.
Gershon A.
Sullivan J.
Bryson Y.
Frenkel L.
Nelson J.
Hadjou G.
Leonardo S.
Riault Y.
Saidi Y.
Buck L.
Darbyshire J. H.
Forcat S.
Horton J.
Johnson D.
Moore S.
Taylor C.
Collins D.
Buskirk S.
Kamara P.
Nesel C.
Johnson M.
Ferreira A.
Tutko J.
Sprenger H.
Britto P.
Powell C.
Dersimonian R.
Handelsman E.
Ananworanich J.
Belfrage E.
Blanche S.
Bohlin A. B.
Burger D.
Castelli-Gattinara G.
Clayden P.
De Groot R.
Grosch-Worner I.
Lallemant M.
Levy J.
Marczynska M.
Mellado Pena M. J.
Nadal D.
Peckham C.
Rosado L.
Rosso R.
Rudin C.
Scherpbier H.
Stevanovic M.
Thorne C.
Tovo P. A.
Valerius N.

January 2011

Background: Children with HIV will be on antiretroviral therapy (ART) longer than adults, and theref...

Babiker, A
Castro nee Green, H
Compagnucci, A
Fiscus, S
Giaquinto, C
Gibb, D
Harper, L
Harrison, L
Hughes, M
McKinney, R
Melvin, A
Mofenson, L
Saidi, Y
Smith, M
Tudor-Williams, G
Walker, A

January 2011

BACKGROUND: Children with HIV will be on antiretroviral therapy (ART) longer than adults, and theref...

Penpact, 1 Study Team: Babiker A
Castro nee Green, H
Compagnucci, A
Fiscus, S
Giaquinto, Carlo
Gibb, Dm
Harper, L
Harrison, L
Hughes, M
Mckinney, R
Melvin, A
Mofenson, L
Saidi, Y
Smith, Me
Tudor Williams, G
Walker, As
Brouwers, P
Costello, D
Ferguson, E
Fiscus, S
Hodge, J
Hughes, M
Jennings, C
Melvin, A
Mckinney, R
Mofenson, L
Warshaw, M
Smith, Me
Spector, S
Stiehm, E
Toye, M
Yogev, R
Aboulker, Jp
Babiker, A
Castro, H
Compagnucci, A
DE ROSSI, Anita

January 2011

BACKGROUND: Children with HIV will be on antiretroviral therapy (ART) longer than adults, and theref...

Short communication: High rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy

Sigaloff, Kim C.E.
Kayiwa, Joshua
Musiime, Victor
Calis, Job C.J.
Kaudha, Elizabeth
Mukuye, Andrew
Matama, Christine
Nankya, Immaculate
Nakatudde, Lillian
Dekker, John T.
Hamers, Raph L.
Mugyenyi, Peter
Rinke De Wit, Tobias F.
Kityo, Cissy

June 2013

HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of particular c...

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting

Puthanakit, T.
Jourdain, Gonzague
Suntarattiwong, P.
Chokephaibulkit, K.
Siangphoe, U.
Suwanlerk, T.
Prasitsuebsai, W.
Sirisanthana, V.
Kosalaraksa, P.
Petdachai, W.
Hansudewechakul, R.
Waranawat, N.
Ananworanich, J.

January 2012

Background: Limited data exist for the efficacy of second-line antiretroviral therapy among children...

Long-term virological outcomes, failure and acquired resistance in a large cohort of Ugandan children

Huibers, M. H. W.
Kityo, C.
Boerma, R. S.
Kaudha, E.
Sigaloff, K. C. E.
Balinda, S. N.
Bertagnolio, S.
Nakanjako, R.
Mugyenyi, P.
Calis, J. C. J.
Boele van Hensbroek, M.
Rinke de Wit, T. F.

October 2019

OBJECTIVES: To evaluate long-term virological failure (VF) and drug resistance among HIV-infected Ug...

Early virological failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children

Theodore D. Ruel
Moses R. Kamya
Mbchb Mmed Mph
Pelin Li
Edwin D. Charlebois
Mph Phd
Teri Liegler
Grant Dorsey
Md Phd
Philip J. Rosenthal
Diane V. Havlir
Joseph K. Wong
Jane Achan
Mbchb Mmed

October 2015

Background—Without virologic testing, HIV-infected African children starting antiretroviral (ARV)-th...

Szubert, A
Prendergast, A
Spyer, M
Musiime, V
Musoke, P
Bwakura-Dangarembizi, M
Nahirya-Ntege, P
Thomason, M
Ndashimye, E
Nankya, I
Senfuma, O
Mudenge, B
Klein, N
Gibb, D
Walker, A

January 2017

Background: Although WHO recommends viral load (VL) monitoring on antiretroviral therapy (ART), avai...

Second-line HIV treatment in ugandan children: Favorable outcomes and no protease inhibitor resistance

Abstract

Extracted data

Second-line HIV treatment in ugandan children: Favorable outcomes and no protease inhibitor resistance

Abstract

Extracted data

Related items

Related items